Access links:
CONTENT
Destacados
Molecular Epidemiology
Publications
-
Mortality in Well Controlled HIV in the Continuous Antiretroviral Therapy Arms of the SMART and...
DOI:10.1097/QAD.0b013e32835cae9c
Background: Due to the success of antiretroviral therapy (ART) it is relevant to ask if death rates in optimally treated HIV are...
-
HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32
Immunobiology(2012). DOI:10.1016/j.imbio.2012.06.012.
Homozygosity for a 32bp deletion in CCR5 (CCR5-Δ32/Δ32) is associated with strong resistance against HIV-1 infection. Several...
-
Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated...
Objective: To explore the potential of deep HIV-1 sequencing for adding clinically relevant information relative to viral...
-
Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment...
JAMA, April 6, 2011—Vol 305, No. 13
Context Presence of low-frequency, or minority, human immunodeficiency virus type 1 (HIV-1) drug resistance mutations may...
Seminars and Congresses
AIDS Vaccine 2013 - BARCELONA
07.10.13bb AIDS Vaccine is the largest and most diverse international meeting of researchers, advocates, clinicians, private sector partners and...
- 19.03.13 - 19.03.13
[IrsiCaixa Seminar] Will it be possible to live without cART? Natural and induced control of HIV-infection
IrsiCaixa Seminar: Will it be possible to live without cART? Natural and induced control of HIV-infection
Lecturer: Asier Sáez-Cirión.
More information
Projects
CCR5 / CXCR4 co-receptor tropism prediction in chronically HIV-1-infected subjects with suppressed viremia using...
Financing entity: Pfizer Spain, S.A.
Participant entities:
Research Supervisor(s): Roger Paredes
